IZREVLU
LIVE

Serial Number

79440401

Owner

Novartis AG

Filing Date

Nov 12, 2025

Add to watchlist:

No watchlists yet
View on USPTO

IZREVLU Trademark

Serial Number: 79440401

IZREVLU is a trademark filed by Novartis AG on November 12, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Novartis AG

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

November 12, 2025

Registration Date

Not Registered

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 7, 2026 RFCR
NON-FINAL ACTION WRITTEN
Feb 6, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 30, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 29, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 29, 2026 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 26, 2026 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 1, 2026 REPR